US FDA Accepts Uganda’s Dei BioPharma’s Application for Diabetes and Weight Loss Drug
The U.S. Food and Drug Administration (FDA) has accepted an Abbreviated New Drug Application (ANDA) from Uganda’s Dei BioPharma for liraglutide, a multibillion-dollar treatment for diabetes and weight loss, marketed under the brand name Victoza. The FDA’s decision, officially recorded on April 23, 2025, clears a path for Dei BioPharma
Exclusive Story: Uganda loses Shs 604 billion following USAID aid cut
The Minister of Health, Dr. Ruth Aceng, has revealed that Uganda lost Shs 604 billion in funding due to the U.S. government’s decision to cut foreign aid worldwide. This funding supported crucial health programs, including HIV/AIDS, malaria, tuberculosis, nutrition services, and payment of salaries. Dr. Aceng made this appeal during
